Form 4 for XTNT Xtant Medical Holdings, Inc.
Accepted 2026-02-18 00:00:00 ET · period of report 2026-02-15 · accession 0001960742-26-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-18 | 2026-02-15 | XTNT | Schallenberger Mark A. | COO | F - Tax | $0.58 | -7,709 | 663.2K | -1% | -$4,471 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-15 | F | D | 7,709 | $0.58 | 663,157 | D | — | — | (F1) These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards. (F2) Includes an aggregate of 523,794 shares issuable upon vesting and settlement of restricted stock unit (RSU) awards or DSU awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan and 22,250 shares issuable upon vesting and settlement of RSU awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the applicable vesting dates. |